Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.



In This Section

Home / Attend / ACCC 46th Annual Meeting & Cancer Center Business Summit

ACCC 46th Annual Meeting & Cancer Center Business Summit



Highlights from Washington, D.C.

The ACCC 46th Annual Meeting & Cancer Center Business Summit, March 4-6, brought together 800 attendees from organizations across the healthcare ecosystem. Exploring the convergence of business, policy, and technology, attendees walked away with tangible takeaways to better develop and streamline services, market programs, and keep costs in check.

As heard in the “Collaborate, Educate, Compensate. Creating a Sustainable Model for Cancer Care Delivery” session on Friday, ACCC has re-launched the Comprehensive Cancer Care Services Survey and your feedback is more important than ever! Help ACCC gather the data it needs to influence federal policy and reimbursement methodologies to include comprehensive cancer care services. The first 100 individuals who fully complete the survey will receive a $50 gift card.

Download the ACCC Comprehensive Care Services Matrix that was discussed during the session, then share with your cancer program and/or practice to gather additional feedback from your team members. Learn more and download the matrix here.


Session Presentations

Access presentations through the desktop version of our meeting app. Please enter the login credentials you created when you downloaded the app. Once logged in, choose a session and scroll down to Presentations to download and save. Questions? Contact Gloria Kombe.



ACCCBuzz Blog Posts

AMCCBS Addresses Federal Healthcare Policy

March 13, 2020

“In this town, we’ve seen healthcare become a political lightning rod,” U.S. Senator Debbie Stabenow (D-MI) told attendees on March 5 at the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C.

As our nation grapples with unprecedented challenges—both individually and collectively—posed by the world-wide novel COVID-19 outbreak, it seems as though lightning has indeed struck and clearly illuminated areas where change is critically needed. 

To move forward with healthcare reform, Senator Stabenow told conference attendees, “We need to start not from a political or ideological position, but from a position of what works and how to make things better.”

She urged oncology professionals to stay engaged in policy development. “When you speak up, people listen. You can and must remain engaged and help us move forward in a positive way. I know this can be done.”

At this moment, the U.S. healthcare system is certainly in the spotlight, and this high-voltage topic continues to amp up in this election year. As the country deals with the healthcare complexities unleashed by the COVID-19 virus, awareness of the flaws and gaps in our healthcare delivery system is heightened. We are witnessing the real-world, practical necessity of leveraging technology to improve healthcare delivery, and, in particular, the critical value of integrating telehealth and telemedicine into our healthcare system. As we experience the uncertainties surrounding the COVID-19 outbreak, a comment by Senator Stabenow crystalizes our reality: “For every one of us, healthcare is not political. It's personal.”

200305_101123_JWRIn the midst of this turbulent landscape, with the presidential campaigns gathering momentum, conference attendees heard perspectives from policy experts Kavita Patel, MD, MS, a Non-Resident Fellow in Economic Studies at the USC-Brookings Schaeffer Initiative for Health Policy and Vice President of Johns Hopkins Medicine; and Paul Edattel, Principal of Todd Strategy, LLC. Moderating the conversation was Dennis A. Cardoza, Director of Public Affairs at Foley & Lardner LLP.  

Before the prognosticating began, Cardoza asked attendees to weigh in on the state of healthcare in the U.S. in 2020. In live polling, here’s what they had to say (see image below):

Poll Question AMCCBSWith three-quarters of respondents perceiving our healthcare system to be resting on shaky ground, Dr. Patel and Paul Edattel shared their views on how the November elections will (or will not) impact federal healthcare policy:

  • Value Models. These are here to stay, speakers agreed. “If you're in a value model, I think those trends continue,” said Dr. Patel. “We will see continuous downward pressure to reduce costs.”


  • Drug Pricing and International Pricing Index. While both Edattel and Dr. Patel agreed that “Nothing is going to get done on drug pricing this year,” the fact that legislation has been proposed is a signal that this issue is not going away.


  • Medicaid Block Grants: “I’m not a fan of block grants,” said Dr. Patel. She noted that when states have a fluctuation in Medicaid enrollees or changes in costs, “They will have to make some arcane policy cuts.” For patients with cancer, she added, “There could be real scenarios … that make it difficult for them to have access to care, drugs. People have to play through what that will look like when they reach their cap.”

    “People aren’t thinking about Medicaid costs in a rational way,” said Edattel. “Medicaid is about 25 percent of total state spending. That’s not sustainable. There will be a resurgence of looking at these programs … in terms of sustainability.”


  • The Supreme Court’s Pending Decision on ACA: Opinions were aligned on this as well. Both speakers believe that the Supreme Court’s decision is not likely to impact coverage provisions of the Affordable Care Act (ACA). “The individual mandate will fall,” predicted Edattel, “but the rest of the ACA will stay in place.”

    “A more important question for cancer care may be Medicare Advantage,” noted Dr. Patel. “If you’re in an area with low penetration of Medicare Advantage, that is not going to continue.”


  • Surprise Billing: “Members [of Congress] want to get something done on this issue for their constituents,” said Edattel. “It has united legislators on both sides.” Edattel further noted that support for the legislation is not dividing along party lines, but according to whether the legislator supports the provider or payer perspective on this issue. “Members of congress are having trouble understanding ramifications of surprise medical billing,” added Dr. Patel. “[The discussion is] not going to the level of understanding of what the impact is on providers.”


  • 340B Program: “I don't think the spotlight on 340B is going to go away anytime soon,” said Edattel. “I completely agree,” responded Dr. Patel. “You're going to get regulatory as well as legislative movement on this.”

As the conversation concluded, Cardoza asked for final thoughts. Edattel reminded attendees, “Pay close attention to CMMI. It has a new leader. We're likely to see some impactful models come in the next few months. CMMI is required to put the final Radiation Oncology Model out there.” Dr. Patel turned to the topic of telehealth. “We still have very little uptake of telecare,” she said. “You could offer it [now]. We don’t offer it very well. Shocking or not, people still want to see the doctor face-to-face.”



AMCCBS Featured videos

View OBR Daily’s video coverage of important oncology topics at #AMCCBS:

video Oyer 500x277

Randall Oyer, MD, shares goals as the incoming President of ACCC.


video Hubbard 500x277

Anne Hubbard, MBA, on whether the new radiation oncology payment model will save on overall cost.


video Wilfong 500x277

Lalan Wilfong, MD, shares knowledge on how to thrive in the rapidly evolving Alternative Payment Model landscape.


video Bosserman 500x277

Linda Bosserman, MD, on operational strategies that cancer program should know when implementing telehealth.

video McBride 500x277

Ali McBride, PharmD, explains what he would accomplish if he had one more year as ACCC President.

video McAneny 500x277

Barbara McAneny, MD, on why oncologists should participate with the American Medical Association.


Explore Our Photo Album

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Media Partners




logo-ACCC-200x80logo-CCBD-200x80  logo-Foley&Lardener-200x80